These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35801577)

  • 21. A dysfunctional miR-1-TRPS1-MYOG axis drives ERMS by suppressing terminal myogenic differentiation.
    Hüttner SS; Henze H; Elster D; Koch P; Anderer U; von Eyss B; von Maltzahn J
    Mol Ther; 2023 Sep; 31(9):2612-2632. PubMed ID: 37452493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-type-specific activation of p38 protein kinase cascades by the novel tumor promoter palytoxin.
    Li S; Wattenberg EV
    Toxicol Appl Pharmacol; 1999 Oct; 160(2):109-19. PubMed ID: 10527909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines.
    Kouraklis G; Triche TJ; Wesley R; Tsokos M
    Pediatr Res; 1999 Apr; 45(4 Pt 1):552-8. PubMed ID: 10203148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential regulation of anti-inflammatory genes by p38 MAP kinase and MAP kinase kinase 6.
    Hammaker D; Boyle DL; Topolewski K; Firestein GS
    J Inflamm (Lond); 2014; 11():14. PubMed ID: 24855454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL.
    Huang H; Ryu J; Ha J; Chang EJ; Kim HJ; Kim HM; Kitamura T; Lee ZH; Kim HH
    Cell Death Differ; 2006 Nov; 13(11):1879-91. PubMed ID: 16498455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-Myc Sustains Transformed Phenotype and Promotes Radioresistance of Embryonal Rhabdomyosarcoma Cell Lines.
    Gravina GL; Festuccia C; Popov VM; Di Rocco A; Colapietro A; Sanità P; Monache SD; Musio D; De Felice F; Di Cesare E; Tombolini V; Marampon F
    Radiat Res; 2016 Apr; 185(4):411-22. PubMed ID: 27104757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of mitogen-activated protein kinase kinase (MKK) 3 and MKK6 by type I interferons.
    Li Y; Batra S; Sassano A; Majchrzak B; Levy DE; Gaestel M; Fish EN; Davis RJ; Platanias LC
    J Biol Chem; 2005 Mar; 280(11):10001-10. PubMed ID: 15644321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Negative regulation of TGF-β1-induced MKK6-p38 and MEK-ERK signalling and epithelial-mesenchymal transition by Rac1b.
    Witte D; Otterbein H; Förster M; Giehl K; Zeiser R; Lehnert H; Ungefroren H
    Sci Rep; 2017 Dec; 7(1):17313. PubMed ID: 29229918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and activation of mitogen-activated protein kinase kinases-3 and -6 in rheumatoid arthritis.
    Chabaud-Riou M; Firestein GS
    Am J Pathol; 2004 Jan; 164(1):177-84. PubMed ID: 14695331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction of p38 with its upstream kinase MKK6.
    Kumar GS; Page R; Peti W
    Protein Sci; 2021 Apr; 30(4):908-913. PubMed ID: 33554397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-alpha-induced expression of monocyte-chemoattractant protein-1 in endothelial cells.
    Goebeler M; Kilian K; Gillitzer R; Kunz M; Yoshimura T; Bröcker EB; Rapp UR; Ludwig S
    Blood; 1999 Feb; 93(3):857-65. PubMed ID: 9920834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of MAPK kinase 6 in arthritis: distinct mechanism of action in inflammation and cytokine expression.
    Yoshizawa T; Hammaker D; Boyle DL; Corr M; Flavell R; Davis R; Schett G; Firestein GS
    J Immunol; 2009 Jul; 183(2):1360-7. PubMed ID: 19561096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific.
    Baudhuin LM; Cristina KL; Lu J; Xu Y
    Mol Pharmacol; 2002 Sep; 62(3):660-71. PubMed ID: 12181443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
    van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
    Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells.
    Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z
    Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1.
    McDermott EP; O'Neill LA
    J Biol Chem; 2002 Mar; 277(10):7808-15. PubMed ID: 11744690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.
    Birkenkamp KU; Tuyt LM; Lummen C; Wierenga AT; Kruijer W; Vellenga E
    Br J Pharmacol; 2000 Sep; 131(1):99-107. PubMed ID: 10960075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of p38 MAPK by MAPK kinases 3 and 6 in fibroblast-like synoviocytes.
    Inoue T; Hammaker D; Boyle DL; Firestein GS
    J Immunol; 2005 Apr; 174(7):4301-6. PubMed ID: 15778394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness.
    Chiappalupi S; Riuzzi F; Fulle S; Donato R; Sorci G
    Carcinogenesis; 2014 Oct; 35(10):2382-92. PubMed ID: 25123133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway.
    Ludwig S; Hoffmeyer A; Goebeler M; Kilian K; Häfner H; Neufeld B; Han J; Rapp UR
    J Biol Chem; 1998 Jan; 273(4):1917-22. PubMed ID: 9442025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.